STEPHEN JOHNSON PATRICK
No ORCID on file
· 14 papers in corpus
· active 2008
Frequent coauthors
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…
2008
The present invention relates to compounds of formula (1), or a pharmaceutically acceptable derivative thereof, wherein R and R independently represent H, C1-6alkyl, C3-8cycloalkyl, or halogen R represents C1-6alkyl, CF3 or aryl a represent…